These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B. Taravaud A, Loiseau PM, Pomel S. Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):328-336. PubMed ID: 28918001 [Abstract] [Full Text] [Related]
6. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis. Gueudry J, Le Goff L, Compagnon P, Lefevre S, Colasse E, Aknine C, Duval F, François A, Razakandrainibe R, Ballet JJ, Muraine M, Favennec L. J Antimicrob Chemother; 2018 Jul 01; 73(7):1895-1898. PubMed ID: 29596605 [Abstract] [Full Text] [Related]
7. In Vitro Amoebicidal Activity of Imidazolium Salts Against Trophozoites. Fabres LF, da Costa Gonçalves F, Duarte EOS, Berté FK, da Conceição DKSL, Ferreira LA, Schrekker HS, Rott MB. Acta Parasitol; 2020 Jun 01; 65(2):317-326. PubMed ID: 31939031 [Abstract] [Full Text] [Related]
8. The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii. Shing B, Singh S, Podust LM, McKerrow JH, Debnath A. Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32094126 [Abstract] [Full Text] [Related]
10. Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole. Talbott M, Cevallos V, Chen MC, Chin SA, Lalitha P, Seitzman GD, Lietman TM, Keenan JD. Cornea; 2019 Oct 21; 38(10):1309-1313. PubMed ID: 31306283 [Abstract] [Full Text] [Related]
11. Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro. Mito T, Suzuki T, Kobayashi T, Zheng X, Hayashi Y, Shiraishi A, Ohashi Y. Invest Ophthalmol Vis Sci; 2012 Sep 19; 53(10):6305-13. PubMed ID: 22918636 [Abstract] [Full Text] [Related]
13. Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51). Lamb DC, Warrilow AG, Rolley NJ, Parker JE, Nes WD, Smith SN, Kelly DE, Kelly SL. Antimicrob Agents Chemother; 2015 Aug 19; 59(8):4707-13. PubMed ID: 26014948 [Abstract] [Full Text] [Related]
14. Anti-Acanthamoeba metallopharmaceuticals: Amoebicidal activity and synergistic effect of copper(II) coordination compound. da Silveira J, Cardoso AP, Fernandes C, Junior AH, da Rosa Monte Machado G, Caumo KS. Biometals; 2024 Oct 19; 37(5):1225-1236. PubMed ID: 38647983 [Abstract] [Full Text] [Related]
15. Antiamoebic activity of 3-aryl-6,7-dimethoxyquinazolin-4(3H)-one library against Acanthamoeba castellanii. Shahbaz MS, Anwar A, Saad SM, Kanwal, Anwar A, Khan KM, Siddiqui R, Khan NA. Parasitol Res; 2020 Jul 19; 119(7):2327-2335. PubMed ID: 32476058 [Abstract] [Full Text] [Related]
16. Malabaricones from the fruit of Myristica cinnamomea King as potential agents against Acanthamoeba castellanii. Ahmed U, Sivasothy Y, Khan KM, Khan NA, Wahab SMA, Awang K, Othman MA, Anwar A. Acta Trop; 2023 Dec 19; 248():107033. PubMed ID: 37783284 [Abstract] [Full Text] [Related]